BioCentury | Apr 5, 2010
Clinical News

NeuroStat: Phase I data

...Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland). NeuroStat was well tolerated. NeuroVive is majority owned by Maas Biolab LLC...
BioCentury | Nov 23, 2009
Clinical News

NeuroStat: Phase I completed

...cyclosporine A marketed by Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland). NeuroVive is majority owned by Maas Biolab LLC...
BioCentury | May 14, 2009
Cover Story

Beating the brain's bouncer

...functionally analogous insect system may help physiological, pharmacological and toxicology studies." Eskil Elmér, CSO of Maas Biolab LLC...
...Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Genentech Inc. , South San Francisco, Calif. Maas Biolab LLC...
BioCentury | Dec 20, 2004
Clinical News

Cyclosporine regulatory update

...FDA granted Orphan Drug designation to cyclosporin, to treat amyotrophic lateral sclerosis (ALS). Maas BiolAB LLC , Albuquerque...
BioCentury | Nov 15, 1999
Clinical News

Cyclosporine neuroimmunophilin ligand regulatory update

...No. 5,972,924 covering cyclosporine as a neuroprotectant for acute and chronic neurological diseases and conditions. Maas BiolAB LLC...
BioCentury | Mar 1, 1999
Clinical News

Maas BiolAB regulatory update

...covering the use of cyclosporin as a neuroprotectant in treating acute and chronic brain diseases. Maas BiolAB LLC...
Items per page:
1 - 6 of 6
BioCentury | Apr 5, 2010
Clinical News

NeuroStat: Phase I data

...Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland). NeuroStat was well tolerated. NeuroVive is majority owned by Maas Biolab LLC...
BioCentury | Nov 23, 2009
Clinical News

NeuroStat: Phase I completed

...cyclosporine A marketed by Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland). NeuroVive is majority owned by Maas Biolab LLC...
BioCentury | May 14, 2009
Cover Story

Beating the brain's bouncer

...functionally analogous insect system may help physiological, pharmacological and toxicology studies." Eskil Elmér, CSO of Maas Biolab LLC...
...Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Genentech Inc. , South San Francisco, Calif. Maas Biolab LLC...
BioCentury | Dec 20, 2004
Clinical News

Cyclosporine regulatory update

...FDA granted Orphan Drug designation to cyclosporin, to treat amyotrophic lateral sclerosis (ALS). Maas BiolAB LLC , Albuquerque...
BioCentury | Nov 15, 1999
Clinical News

Cyclosporine neuroimmunophilin ligand regulatory update

...No. 5,972,924 covering cyclosporine as a neuroprotectant for acute and chronic neurological diseases and conditions. Maas BiolAB LLC...
BioCentury | Mar 1, 1999
Clinical News

Maas BiolAB regulatory update

...covering the use of cyclosporin as a neuroprotectant in treating acute and chronic brain diseases. Maas BiolAB LLC...
Items per page:
1 - 6 of 6